Innoviva, Inc. (INVA) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Innoviva, Inc. (INVA) Bundle
Explore Innoviva, Inc. (INVA) financial future with our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and costs to calculate Innoviva, Inc. (INVA) intrinsic value and inform your investment approach.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 261.0 | 336.8 | 391.9 | 331.3 | 310.5 | 328.8 | 348.2 | 368.8 | 390.6 | 413.7 |
Revenue Growth, % | 0 | 29.03 | 16.35 | -15.45 | -6.3 | 5.91 | 5.91 | 5.91 | 5.91 | 5.91 |
EBITDA | 265.4 | 386.4 | 478.2 | 322.3 | 249.0 | 314.0 | 332.5 | 352.2 | 373.0 | 395.0 |
EBITDA, % | 101.69 | 114.73 | 122.03 | 97.26 | 80.19 | 95.49 | 95.49 | 95.49 | 95.49 | 95.49 |
Depreciation | 13.9 | 13.8 | 13.8 | 19.5 | 35.7 | 20.0 | 21.1 | 22.4 | 23.7 | 25.1 |
Depreciation, % | 5.32 | 4.11 | 3.53 | 5.89 | 11.5 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 |
EBIT | 251.6 | 372.6 | 464.3 | 302.7 | 213.3 | 300.2 | 317.9 | 336.7 | 356.6 | 377.6 |
EBIT, % | 96.38 | 110.62 | 118.5 | 91.37 | 68.69 | 91.29 | 91.29 | 91.29 | 91.29 | 91.29 |
Total Cash | 350.8 | 246.5 | 201.5 | 291.0 | 193.5 | 246.5 | 261.0 | 276.5 | 292.8 | 310.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 79.4 | 93.9 | 110.7 | 64.1 | 84.1 | 87.5 | 92.6 | 98.1 | 103.9 | 110.0 |
Account Receivables, % | 30.43 | 27.89 | 28.25 | 19.34 | 27.08 | 26.6 | 26.6 | 26.6 | 26.6 | 26.6 |
Inventories | -79.4 | -93.9 | -110.7 | 55.9 | 40.7 | -37.2 | -39.4 | -41.7 | -44.2 | -46.8 |
Inventories, % | -30.43 | -27.89 | -28.25 | 16.87 | 13.12 | -11.32 | -11.32 | -11.32 | -11.32 | -11.32 |
Accounts Payable | .0 | .1 | .0 | 2.9 | 6.7 | 2.0 | 2.1 | 2.3 | 2.4 | 2.5 |
Accounts Payable, % | 0.00383118 | 0.01959655 | 0.00689011 | 0.88701 | 2.16 | 0.61617 | 0.61617 | 0.61617 | 0.61617 | 0.61617 |
Capital Expenditure | .0 | .0 | -1.3 | -.1 | -.4 | -.3 | -.3 | -.4 | -.4 | -.4 |
Capital Expenditure, % | -0.00459742 | -0.00385993 | -0.33277 | -0.02022098 | -0.13238 | -0.09876561 | -0.09876561 | -0.09876561 | -0.09876561 | -0.09876561 |
Tax Rate, % | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 |
EBITAT | 169.9 | 236.0 | 384.6 | 225.7 | 197.5 | 228.6 | 242.1 | 256.5 | 271.6 | 287.7 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 183.8 | 249.9 | 397.1 | 128.1 | 231.7 | 318.1 | 260.1 | 275.5 | 291.7 | 309.0 |
WACC, % | 6.19 | 6.15 | 6.35 | 6.26 | 6.45 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 |
PV UFCF | ||||||||||
SUM PV UFCF | 1,215.6 | |||||||||
Long Term Growth Rate, % | 0.50 | |||||||||
Free cash flow (T + 1) | 311 | |||||||||
Terminal Value | 5,373 | |||||||||
Present Terminal Value | 3,962 | |||||||||
Enterprise Value | 5,178 | |||||||||
Net Debt | 256 | |||||||||
Equity Value | 4,922 | |||||||||
Diluted Shares Outstanding, MM | 87 | |||||||||
Equity Value Per Share | 56.66 |
What You Will Receive
- Pre-Filled Financial Model: Innoviva’s actual data facilitates accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, profit margins, WACC, and other critical drivers.
- Instant Calculations: Automatic updates provide immediate feedback as you adjust parameters.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for versatility, allowing for repeated application in detailed forecasts.
Key Features
- Comprehensive Innoviva Financials: Gain access to precise pre-loaded historical data and future forecasts.
- Adjustable Forecast Parameters: Modify highlighted cells for metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
- Suitable for All Levels: A straightforward, intuitive design tailored for investors, CFOs, and consultants alike.
How It Works
- Download: Obtain the pre-built Excel file containing Innoviva, Inc.'s (INVA) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and analyze results instantly.
- Make Decisions: Utilize the valuation outcomes to inform your investment choices.
Why Choose Innoviva, Inc. (INVA) Calculator?
- Save Time: Skip the hassle of building a model from the ground up – it's ready for immediate use.
- Enhance Accuracy: Dependable financial data and established formulas minimize valuation errors.
- Completely Customizable: Adjust the model to align with your unique assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs facilitate easy result interpretation.
- Endorsed by Professionals: Crafted for experts who prioritize both precision and functionality.
Who Should Use Innoviva, Inc. (INVA)?
- Investors: Gain insights and make informed decisions with cutting-edge research on Innoviva's market potential.
- Financial Analysts: Utilize comprehensive data and analytics to evaluate Innoviva's performance and prospects.
- Consultants: Tailor reports and presentations for clients by leveraging Innoviva's strategic initiatives and developments.
- Healthcare Professionals: Enhance your understanding of Innoviva's impact on the pharmaceutical landscape and patient care.
- Students and Educators: Explore real-world case studies of Innoviva to enrich finance and healthcare education.
What the Template Contains
- Pre-Filled DCF Model: Innoviva, Inc.’s (INVA) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Innoviva, Inc.’s (INVA) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.